These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. High Mobility Group Box 1 Protein: A Plausible Therapeutic Molecular Target in Parkinson's Disease. Goyal A; Agrawal A; Dubey N; Verma A Curr Pharm Biotechnol; 2024; 25(8):937-943. PubMed ID: 37670710 [TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD. Esteves AR; Arduíno DM; Silva DF; Oliveira CR; Cardoso SM Parkinsons Dis; 2011 Jan; 2011():693761. PubMed ID: 21318163 [TBL] [Abstract][Full Text] [Related]
14. Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation. Kline EM; Houser MC; Herrick MK; Seibler P; Klein C; West A; Tansey MG Mov Disord; 2021 Jan; 36(1):25-36. PubMed ID: 33314312 [TBL] [Abstract][Full Text] [Related]
15. The systemic immune response in Parkinson's disease: focus on the peripheral immune component. Lauritsen J; Romero-Ramos M Trends Neurosci; 2023 Oct; 46(10):863-878. PubMed ID: 37598092 [TBL] [Abstract][Full Text] [Related]
16. The Role of Immune Dysfunction in Parkinson's Disease Development. Cossu D; Hatano T; Hattori N Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069088 [TBL] [Abstract][Full Text] [Related]
17. Central and peripheral innate and adaptive immunity in Parkinson's disease. Harms AS; Yang YT; Tansey MG Sci Transl Med; 2023 Nov; 15(721):eadk3225. PubMed ID: 37939158 [TBL] [Abstract][Full Text] [Related]
18. A central role for mitochondrial-derived vesicles in the innate immune response: implications for Parkinson's disease. Ryan TA; Tumbarello DA Neural Regen Res; 2021 Sep; 16(9):1779-1780. PubMed ID: 33510074 [No Abstract] [Full Text] [Related]